171 related articles for article (PubMed ID: 37443196)
1. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.
Fang H; Beird HC; Wang SA; Ibrahim AF; Tang Z; Tang G; You MJ; Hu S; Xu J; Li S; Yin CC; El Hussein S; Le N; Futreal PA; Bueso-Ramos C; Thakral B; Kadia TM; Thornton R; Little L; Gumbs C; Song X; Medeiros LJ; Wang W
Leukemia; 2023 Sep; 37(9):1919-1921. PubMed ID: 37443196
[No Abstract] [Full Text] [Related]
2. Comparison of karyotyping,
Sun Y; Tang G; Hu Z; Thakral B; Miranda RN; Medeiros LJ; Wang SA
J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia.
Gritti C; Dastot H; Soulier J; Janin A; Daniel MT; Madani A; Grimber G; Briand P; Sigaux F; Stern MH
Blood; 1998 Jul; 92(2):368-73. PubMed ID: 9657733
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic Blebs in T-Cell Prolymphocytic Leukemia.
Abbas HA; Han X
N Engl J Med; 2019 Jun; 380(24):2360. PubMed ID: 31189039
[No Abstract] [Full Text] [Related]
5. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract][Full Text] [Related]
6. [Transgenic mice expressing MTCP1: an animal model for T-cell prolymphocytic leukemia].
Chiali-Gritti C
Ann Pharm Fr; 2000 Jan; 58(1):54-61. PubMed ID: 10669814
[TBL] [Abstract][Full Text] [Related]
7. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
[TBL] [Abstract][Full Text] [Related]
8. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
Yokohama A; Saitoh A; Nakahashi H; Mitsui T; Koiso H; Kim Y; Uchiumi H; Saitoh T; Handa H; Jimbo T; Murayama K; Sakura T; Murakami H; Karasawa M; Nojima Y; Tsukamoto N
Int J Hematol; 2012 Jan; 95(1):77-85. PubMed ID: 22189846
[TBL] [Abstract][Full Text] [Related]
9. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
Herling M; Patel KA; Teitell MA; Konopleva M; Ravandi F; Kobayashi R; Jones D
Blood; 2008 Jan; 111(1):328-37. PubMed ID: 17890451
[TBL] [Abstract][Full Text] [Related]
10. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
Cao TM; Coutre SE
Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
[TBL] [Abstract][Full Text] [Related]
11. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
12. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
Thick J; Metcalfe JA; Mak YF; Beatty D; Minegishi M; Dyer MJ; Lucas G; Taylor AM
Oncogene; 1996 Jan; 12(2):379-86. PubMed ID: 8570215
[TBL] [Abstract][Full Text] [Related]
13. T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation.
Torabi A; Naresh KN
Blood; 2023 Jul; 142(1):119. PubMed ID: 37410504
[No Abstract] [Full Text] [Related]
14. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
[TBL] [Abstract][Full Text] [Related]
15. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.
Soulier J; Pierron G; Vecchione D; Garand R; Brizard F; Sigaux F; Stern MH; Aurias A
Genes Chromosomes Cancer; 2001 Jul; 31(3):248-54. PubMed ID: 11391795
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology.
Hoh F; Yang YS; Guignard L; Padilla A; Stern MH; Lhoste JM; van Tilbeurgh H
Structure; 1998 Feb; 6(2):147-55. PubMed ID: 9519406
[TBL] [Abstract][Full Text] [Related]
17. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
18. [Oncogenesis of T-cell prolymphocytic leukemia].
Stern MH
Pathol Biol (Paris); 1996 Oct; 44(8):689-93. PubMed ID: 8977926
[TBL] [Abstract][Full Text] [Related]
19. Array comparative genomic hybridization in the detection of chromosomal abnormalities in T-cell prolymphocytic leukemia.
Urbánková H; Holzerová M; Balcárková J; Raida L; Procházka V; Pikalová Z; Papajík T; Indrák K; Jarosová M
Cancer Genet Cytogenet; 2010 Oct; 202(1):58-62. PubMed ID: 20804923
[No Abstract] [Full Text] [Related]
20. T-cell prolymphocytic leukaemia: antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation.
De Schouwer PJ; Dyer MJ; Brito-Babapulle VB; Matutes E; Catovsky D; Yuille MR
Br J Haematol; 2000 Sep; 110(4):831-8. PubMed ID: 11054065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
